Abstract
Allergic diseases are pathological immune responses with significant morbidity, which are closely associated with allergic mediators as released by allergen‐stimulated mast cells (MCs). Prophylactic stabilization of MCs is regarded as a practical approach to prevent allergic diseases. However, most of the existing small molecular MC stabilizers exhibit a narrow therapeutic time window, failing to provide long‐term prevention of allergic diseases. Herein, ceria nanoparticle (CeNP‐) based phosphatase‐mimetic nano‐stabilizers (PMNSs) with a long‐term therapeutic time window are developed for allergic disease prevention. By virtue of the regenerable catalytic hotspots of oxygen vacancies on the surface of CeNPs, PMNSs exhibit sustainable phosphatase‐mimetic activity to dephosphorylate phosphoproteins in allergen‐stimulated MCs. Consequently, PMNSs constantly modulate intracellular phospho‐signaling cascades of MCs to inhibit the degranulation of allergic mediators, which prevents the initiation of allergic mediator‐associated pathological responses, eventually providing protection against allergic diseases with a long‐term therapeutic time window.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.